Covid-19 (Coronavirus) External Quality Assessment

Covid-19 External Quality Assessment

UK NEQAS are pleased to offer external quality assessment (EQA) programmes to laboratories when diagnosing, treating and monitoring Covid-19.

Diagnostic EQA Programmes

  • SARS-CoV-2 Antibody Test (Pilot), UK NEQAS Immunology, Immunochemistry & Allergy
  • SARS-CoV-2 Molecular Test (Pilot), UK NEQAS Microbiology
  • Troponin (1, 2, 3), UK NEQAS Cardiac Markers

Please contact us for further information, or to register your interest in any of the diagnostic EQA programmes above.

Treatment and Monitoring EQA Programmes

  • APTT (2), UK NEQAS Clinical Chemistry (Birmingham Quality)
  • B-Type Natriuretic Peptide (BNP) (3, 4), UK NEQAS Cardiac Markers
  • C-Reactive Protein (2), UK NEQAS Immunology, Immunochemistry & Allergy
  • D-Dimer Assay (2), UK NEQAS Blood Coagulation
  • Ferritin (2, 5), UK NEQAS Clinical Chemistry (Birmingham Quality)
  • Fibrinogen (2), UK NEQAS Blood Coagulation
  • Full Blood Count (2), UK NEQAS General Haematology
  • HIT Screening (6), UK NEQAS Blood Coagulation
  • Interleukin-6 (3, 7), UK NEQAS Immunology, Immunochemistry & Allergy
  • Monitoring Anticoagulation with LMWH & UFH (8), UK NEQAS Blood Coagulation
  • NT-proBNP (4), UK NEQAS Cardiac Markers
  • Procalcitonin (2), UK NEQAS Microbiology
  • Prothrombin Time (2), UK NEQAS Blood Coagulation
  • Routine Biochemistry (5), UK NEQAS Immunology, Immunochemistry & Allergy
  • Troponin (1, 2, 3), UK NEQAS Cardiac Markers

Please contact us for further information, or to register your interest in any of the treatment and monitoring EQA programmes above.

Educational Modules

  • Individual Competency Assessment for Covid-19 Testing
    Suitable for all who work in laboratories receiving and processing SARS-CoV-2 virus samples. Primarily aimed at non-NHS staff,
  • Individual Competency Assessment for Covid-19 Swabbing
    Suitable for UK care home workers who are taking swab samples from residents for SARS-CoV-2 virus testing.

Please contact us for further information, or to register your interest in any of the educational modules above.

 


Did you know that UK NEQAS is on Twitter? Check out our Twitter page and follow us for the latest related news and updates.

 

 

Reference List

  1. Chapman, A.R., Bularga, A. and Mills, N.L. (2020). High-Sensitivity Cardiac Troponin Can Be An Ally in the Fight Against COVID-19. Circulation. Available at: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047008 Accessed 20 May 2020
  2. Favaloro, E.J. and Lippi, G. (2020). Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring. Seminars in Thrombosis and Hemostasis, 46(03), pp.379–382
  3. O’Neill, A. (2020).troponin and IL-6 levels associated with poor prognosis in COVID-19. [online] Cardiac Rhythm News. Available at: https://cardiacrhythmnews.com/raised-troponin-and-interleukin-6-levels-are-associated-with-a-poor-prognosis-in-covid-19/ [Accessed 24 Apr. 2020].
  4. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis [published online ahead of print, 2020 Apr 10]. Clin Chem Lab Med. 2020;/j/cclm.ahead-of-print/cclm-2020-0369/cclm-2020-0369.xml. doi:10.1515/cclm-2020-0369
  5. Liu, P.P., Blet, A., Smyth, D. and Li, H. (2020). The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation. Available at: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047549 |Accessed 20 May 2020
  6. Jing-Chun Song et al (2020), Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19.   Mil Med Res;  7: p19
  7. Mehta, P., McAuley, D.F., Brown, M., Sanchez, E., Tattersall, R.S. and Manson, J.J. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet, [online] 395(10229), pp.1033–1034. Available at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30628-0/fulltext.
  8. Tang N et al (2020).  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. ;18(5):pp1094-109